Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-14 Purchase |
2024-05-15 4:13 pm |
LENZ Therapeutics Inc. | LENZ | Chevallard Daniel R. Chief Financial Officer |
3,188 | $15.68 | $49,988 | 3,188 (Direct) |
View |
| 2024-05-13 Purchase |
2024-05-14 5:29 pm |
LENZ Therapeutics Inc. | LENZ | MCCOLLUM JAMES W Director |
31,332 | $15.99 | $501,093 | 620,599 (Indirect Direct) |
View |
| 2024-03-21 Purchase |
2024-03-25 8:48 pm |
LENZ Therapeutics Inc. | LENZ | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
998,009 | $15.03 | $15,000,075 | 792,288 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-09 Exercise |
2025-04-09 7:20 pm |
N/A N/A |
LENZ Therapeutics Inc. | LENZ | Olsson Shawn Chief Commercial Officer |
1,400 | $2.08 | 67,974 (Direct) |
View |
| 2025-04-09 Exercise |
2025-04-09 7:20 pm |
N/A 2031-08-18 |
LENZ Therapeutics Inc. | LENZ | Olsson Shawn Chief Commercial Officer |
1,400 | $0 | 67,974 (Direct) |
View |
| 2025-03-07 Exercise |
2025-03-07 6:10 pm |
N/A 2031-03-07 |
LENZ Therapeutics Inc. | LENZ | Schimmelpennink Evert B. President, CEO and Secretary |
4,200 | $0 | 387,106 (Direct) |
View |
| 2025-03-07 Exercise |
2025-03-07 6:10 pm |
N/A N/A |
LENZ Therapeutics Inc. | LENZ | Schimmelpennink Evert B. President, CEO and Secretary |
4,200 | $1.04 | 387,106 (Direct) |
View |
| 2025-01-09 Option Award |
2025-01-13 5:26 pm |
N/A 2035-01-08 |
LENZ Therapeutics Inc. | LENZ | Olsson Shawn Chief Commercial Officer |
80,100 | $0 | 80,100 (Direct) |
View |
| 2025-01-09 Option Award |
2025-01-13 5:24 pm |
N/A 2035-01-08 |
LENZ Therapeutics Inc. | LENZ | Odrich Marc Chief Medical Officer |
80,100 | $0 | 80,100 (Direct) |
View |
| 2025-01-09 Option Award |
2025-01-13 5:22 pm |
N/A 2035-01-08 |
LENZ Therapeutics Inc. | LENZ | Chevallard Daniel R. Chief Financial Officer |
70,444 | $0 | 70,444 (Direct) |
View |
| 2025-01-09 Option Award |
2025-01-13 5:20 pm |
N/A 2035-01-08 |
LENZ Therapeutics Inc. | LENZ | Schimmelpennink Evert B. President, CEO and Secretary |
279,100 | $0 | 279,100 (Direct) |
View |
| 2024-12-16 Exercise |
2024-12-17 7:55 pm |
N/A N/A |
LENZ Therapeutics Inc. | LENZ | Olsson Shawn Chief Commercial Officer |
3,333 | $2.08 | 67,974 (Direct) |
View |
| 2024-12-16 Exercise |
2024-12-17 7:55 pm |
N/A 2031-08-18 |
LENZ Therapeutics Inc. | LENZ | Olsson Shawn Chief Commercial Officer |
3,333 | $0 | 67,974 (Direct) |
View |
| 2024-07-22 Exercise |
2024-07-23 8:16 pm |
N/A 2031-03-07 |
LENZ Therapeutics Inc. | LENZ | Schimmelpennink Evert B. President, CEO and Secretary |
45,000 | $0 | 387,106 (Direct) |
View |
| 2024-07-22 Exercise |
2024-07-23 8:16 pm |
N/A N/A |
LENZ Therapeutics Inc. | LENZ | Schimmelpennink Evert B. President, CEO and Secretary |
45,000 | $1.04 | 387,106 (Direct) |
View |
Ownership |
2024-03-28 4:31 pm |
N/A N/A |
LENZ Therapeutics Inc. | LENZ | Alpha Wave Ventures GP Ltd Alpha Wave Global LP Lunate Holding RSC Ltd Chimera Investment LLC 10% Owner |
0 | $0 | 3,612,211 (Indirect) |
View |
| 2024-03-21 Option Award |
2024-03-25 8:48 pm |
2024-03-21 2027-10-30 |
LENZ Therapeutics Inc. | LENZ | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
3,343,318 | $0 | 792,288 (Indirect) |
View |
| 2024-03-21 Option Award |
2024-03-25 8:44 pm |
N/A 2034-03-20 |
LENZ Therapeutics Inc. | LENZ | Thunen Shelley B Director |
27,000 | $0 | 27,000 (Direct) |
View |
| 2024-03-21 Option Award |
2024-03-25 8:42 pm |
2020-10-30 2027-10-30 |
LENZ Therapeutics Inc. | LENZ | MCCOLLUM JAMES W Director |
606,209 | $0 | 622,842 (Indirect) |
View |
| 2024-03-21 Option Award |
2024-03-25 8:42 pm |
N/A N/A |
LENZ Therapeutics Inc. | LENZ | MCCOLLUM JAMES W Director |
16,633 | $15.03 | 622,842 (Indirect) |
View |
| 2024-03-21 Option Award |
2024-03-25 8:40 pm |
N/A 2031-09-16 |
LENZ Therapeutics Inc. | LENZ | Guerard Frederic Director |
81,468 | $0 | 81,468 (Direct) |
View |
| 2024-03-21 Option Award |
2024-03-25 8:40 pm |
N/A 2034-03-20 |
LENZ Therapeutics Inc. | LENZ | Scheiner Zachary Director |
27,000 | $0 | 27,000 (Direct) |
View |
| 2024-03-21 Option Award |
2024-03-25 8:39 pm |
N/A 2034-03-20 |
LENZ Therapeutics Inc. | LENZ | Drapkin Kimberlee C Director |
27,000 | $0 | 27,000 (Direct) |
View |
| 2024-03-21 Option Award |
2024-03-25 8:38 pm |
N/A 2034-03-20 |
LENZ Therapeutics Inc. | LENZ | George Jeffrey P. Director |
27,000 | $0 | 27,000 (Direct) |
View |
| 2024-03-21 Option Award |
2024-03-25 8:36 pm |
N/A 2034-03-20 |
LENZ Therapeutics Inc. | LENZ | Chevallard Daniel R. Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-03-21 Option Award |
2024-03-25 8:34 pm |
N/A 2031-08-18 |
LENZ Therapeutics Inc. | LENZ | Olsson Shawn Chief Commercial Officer |
254,355 | $0 | 254,355 (Direct) |
View |
| 2024-03-21 Option Award |
2024-03-25 8:33 pm |
N/A 2033-06-19 |
LENZ Therapeutics Inc. | LENZ | Odrich Marc Chief Medical Officer |
271,071 | $0 | 271,071 (Direct) |
View |
| 2024-03-21 Option Award |
2024-03-25 8:32 pm |
N/A 2031-03-07 |
LENZ Therapeutics Inc. | LENZ | Schimmelpennink Evert B. President, CEO and Secretary |
1,260,693 | $0 | 1,260,693 (Direct) |
View |
| 2024-03-21 Other |
2024-03-25 4:30 pm |
N/A N/A |
LENZ Therapeutics Inc. | LENZ | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC Versant Venture Capital VII L.P. Versant Ventures VII GP L.P. Versant Ventures VII GP-GP LLC 10% Owner |
598,203 | $0 | 5,140,353 (Indirect) |
View |
Ownership |
2024-03-25 4:19 pm |
N/A N/A |
LENZ Therapeutics Inc. | LENZ | Versant Venture Capital VII L.P. Versant Ventures VII GP L.P. Versant Ventures VII GP-GP LLC 10% Owner |
0 | $0 | 1,669,323 (Direct) |
View |
| 2023-07-28 Option Award |
2023-08-01 8:09 pm |
N/A 2033-07-27 |
Graphite Bio Inc. | GRPH | Drapkin Kimberlee C Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-07-19 Option Award |
2023-07-21 5:13 pm |
N/A 2033-07-18 |
Graphite Bio Inc. | GRPH | Viney Joanne L. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-07-19 Option Award |
2023-07-21 5:12 pm |
N/A 2033-07-18 |
Graphite Bio Inc. | GRPH | Porteus Matthew Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-07-19 Option Award |
2023-07-21 5:10 pm |
N/A 2033-07-18 |
Graphite Bio Inc. | GRPH | KARSEN PERRY A Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-07-19 Option Award |
2023-07-21 5:08 pm |
N/A 2033-07-18 |
Graphite Bio Inc. | GRPH | JIMENEZ JOSEPH Director |
20,000 | $0 | 20,000 (Direct) |
View |